Lettonie - letton - Pārtikas un veterinārais dienests, Zemkopības ministrija

uab ″medicata filia″ - eļļas ekstrakts

Union européenne - letton - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - antineoplastiski līdzekļi - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

Lettonie - letton - Pārtikas un veterinārais dienests, Zemkopības ministrija

medicata filia, uab - tablete

Lettonie - letton - Pārtikas un veterinārais dienests, Zemkopības ministrija

medicata filia, uab - tablete

Lettonie - letton - Pārtikas un veterinārais dienests, Zemkopības ministrija

medicata filia, uab - tablete

Lettonie - letton - Pārtikas un veterinārais dienests, Zemkopības ministrija

medicata filia, sas - tabletes

Lettonie - letton - Pārtikas un veterinārais dienests, Zemkopības ministrija

medicata filia , sas - tabletes

Union européenne - letton - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - cd19-directed genetically modified autologous cell-based product consisting of purified cd8+ t-cells (cd8+ cells), cd19-directed genetically modified autologous cell-based product consisting of purified cd4+ t cells (cd4+ cells) - lymphoma, large b-cell, diffuse; lymphoma, follicular; mediastinal neoplasms - antineoplastiski līdzekļi - breyanzi is indicated for the treatment of adult patients with diffuse large b-cell lymphoma (dlbcl), high grade b-cell lymphoma (hgbcl), primary mediastinal large b-cell lymphoma (pmbcl) and follicular lymphoma grade 3b (fl3b), who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy.

Lettonie - letton - Zāļu valsts aģentūra

sandoz d.d., slovenia - rivaroksabans - apvalkotā tablete - 2,5 mg

Lettonie - letton - Zāļu valsts aģentūra

sandoz d.d., slovenia - rivaroksabans - apvalkotā tablete - 10 mg